3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
4
Lymphoma, Large-Cell, Anaplastic
2
Immunoblastic Lymphadenopathy
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Follicular
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Oxaliplatin
9
Capecitabine
9
pembrolizumab
7
Paclitaxel
7
Fluorouracil
7
Leucovorin
6
Cisplatin
6
zolbetuximab
5
Gemcitabine
4
trastuzumab deruxtecan
3
enzalutamide
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Pemetrexed
3
Docetaxel
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
darolutamide
2
Taxes
2
Ramucirumab
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Nivolumab
2
Irinotecan
2
Cyclophosphamide
2
Androgen Antagonists
2
Albumin-Bound Paclitaxel
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
10-propargyl-10-deazaaminopterin
×
90 days
×
Clear all
No trials found.